Listed

CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Aug 7, 2019 and accepted by EDGAR at Aug 7, 2019, 16:28 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-04-01 to 2019-06-30$63.14bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2019-01-01 to 2019-06-30$124.53bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-04-01 to 2019-06-30$38.97bnus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-01-01 to 2019-06-30$76.22bnus-gaap:CostOfGoodsAndServicesSold
Operating income3 months2019-04-01 to 2019-06-30$3.33bnus-gaap:OperatingIncomeLoss
Operating income6 months2019-01-01 to 2019-06-30$6.02bnus-gaap:OperatingIncomeLoss
Interest expense3 months2019-04-01 to 2019-06-30$772.0mus-gaap:InterestExpense
Interest expense6 months2019-01-01 to 2019-06-30$1.55bnus-gaap:InterestExpense
Income tax3 months2019-04-01 to 2019-06-30$660.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-01-01 to 2019-06-30$1.17bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-04-01 to 2019-06-30$1.94bnus-gaap:NetIncomeLoss
Net income6 months2019-01-01 to 2019-06-30$3.36bnus-gaap:NetIncomeLoss
Diluted EPS3 months2019-04-01 to 2019-06-30$1.49us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2019-01-01 to 2019-06-30$2.58us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-04-01 to 2019-06-30$1.49us-gaap:EarningsPerShareBasic
Basic EPS6 months2019-01-01 to 2019-06-30$2.58us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-04-01 to 2019-06-301,302,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-01-01 to 2019-06-301,302,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-01-01 to 2019-06-30$7.29bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-01-01 to 2019-06-30$1.29bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2019-01-01 to 2019-06-30$1.31bnus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2019-06-30$6.06bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$46.90bnus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$218.90bnus-gaap:Assets
Current liabilitiesAt period end2019-06-30$49.38bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-06-30$157.31bnus-gaap:Liabilities
Long-term debtAt period end2019-06-30$66.94bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-06-30$3.89bnus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2019-06-30$446.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2019-06-30$61.28bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-19-000039. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.